Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6453803, 6 pages
http://dx.doi.org/10.1155/2016/6453803
Research Article

Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy

1Division of Nephrology, Kaohsiung Municipal Feng-Shan Hospital, Kaohsiung, Taiwan
2Department of Electronic Engineering, National Kaohsiung University of Applied Sciences, Kaohsiung, Taiwan
3Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
4Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Received 4 August 2016; Revised 17 October 2016; Accepted 14 November 2016

Academic Editor: Ramazan Akdemir

Copyright © 2016 Shang-Chih Liao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Shimada, H. Hasegawa, Y. Yamazaki et al., “FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis,” Journal of Bone and Mineral Research, vol. 19, no. 3, pp. 429–435, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Komaba and M. Fukagawa, “The role of FGF23 in CKD—with or without Klotho,” Nature Reviews Nephrology, vol. 8, no. 8, pp. 484–490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. E. G. Farrow, S. I. Davis, L. J. Summers, and K. E. White, “Initial FGF23-mediated signaling occurs in the distal convoluted tubule,” Journal of the American Society of Nephrology, vol. 20, no. 5, pp. 955–960, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Bergwitz and H. Jüppner, “Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23,” Annual Review of Medicine, vol. 61, pp. 91–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Juppner, “Phosphate and FGF-23,” Kidney International Supplement, vol. 121, pp. S24–S27, 2011. View at Google Scholar
  6. D. Fliser, B. Kollerits, U. Neyer et al., “Fibroblast Growth Factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) study,” Journal of the American Society of Nephrology, vol. 18, no. 9, pp. 2601–2608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. O. M. Gutiérrez, J. L. Januzzi, T. Isakova et al., “Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease,” Circulation, vol. 119, no. 19, pp. 2545–2552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Russo and Y. Battaglia, “Clinical significance of FGF-23 in patients with CKD,” International Journal of Nephrology, vol. 2011, Article ID 364890, 5 pages, 2011. View at Publisher · View at Google Scholar
  9. M. Kuro-o, Y. Matsumura, H. Aizawa et al., “Mutation of the mouse klotho gene leads to a syndrome resembling ageing,” Nature, vol. 390, no. 6655, pp. 45–51, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Urakawa, Y. Yamazaki, T. Shimada et al., “Klotho converts canonical FGF receptor into a specific receptor for FGF23,” Nature, vol. 444, no. 7120, pp. 770–774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. C. Hu, M. Shi, J. Zhang et al., “Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule,” The FASEB Journal, vol. 24, no. 9, pp. 3438–3450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Chang, S. Hoefs, A. W. Van Der Kemp, C. N. Topala, R. J. Bindels, and J. G. Hoenderop, “The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel,” Science, vol. 310, no. 5747, pp. 490–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Takahashi, H. Komaba, Y. Takahashi et al., “Impact of parathyroidectomy on serum FGF23 and soluble klotho in hemodialysis patients with severe secondary hyperparathyroidism,” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 4, pp. E652–E658, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Sato, Y. Tominaga, T. Ueki et al., “Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism,” American Journal of Kidney Diseases, vol. 44, no. 3, pp. 481–487, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. P. J. Tebben, R. J. Singh, B. L. Clarke, and R. Kumar, “Fibroblast growth factor 23, parathyroid hormone, and 1α,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism,” Mayo Clinic Proceedings, vol. 79, no. 12, pp. 1508–1513, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Schnedl, A. Fahrleitner-Pammer, P. Pietschmann, and K. Amrein, “FGF23 in acute and chronic illness,” Disease Markers, vol. 2015, Article ID 358086, 8 pages, 2015. View at Publisher · View at Google Scholar
  17. I. López, M. E. Rodríguez-Ortiz, Y. Almadén et al., “Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo,” Kidney International, vol. 80, no. 5, pp. 475–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Larsson, U. Nisbeth, Ö. Ljunggren, H. Jüppner, and K. B. Jonsson, “Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers,” Kidney International, vol. 64, no. 6, pp. 2272–2279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. C. Hu, M. Shi, J. Zhang et al., “Klotho deficiency causes vascular calcification in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 22, no. 1, pp. 124–136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kurosu, Y. Ogawa, M. Miyoshi et al., “Regulation of fibroblast growth factor-23 signaling by Klotho,” The Journal of Biological Chemistry, vol. 281, no. 10, pp. 6120–6123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. S. Razzaque and B. Lanske, “The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis,” The Journal of Endocrinology, vol. 194, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Imura, A. Iwano, O. Tohyama et al., “Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane,” FEBS Letters, vol. 565, no. 1–3, pp. 143–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Matsumura, H. Aizawa, T. Shiraki-Iida, R. Nagai, M. Kuro-O, and Y.-I. Nabeshima, “Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein,” Biochemical and Biophysical Research Communications, vol. 242, no. 3, pp. 626–630, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. R. C. Smith, L. M. O'Bryan, E. G. Farrow et al., “Circulating αKlotho influences phosphate handling by controlling FGF23 production,” The Journal of Clinical Investigation, vol. 122, no. 12, pp. 4710–4715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. E. G. Farrow, X. Yu, L. J. Summers et al., “Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 46, pp. E1146–E1155, 2011. View at Publisher · View at Google Scholar · View at Scopus